CHARACTERIZATION OF ACETYLCHOLINESTERASE INHIBITION BY ITOPRIDE

Itopride is a gastroprokinetic benzamide derivative. This agent inhibited both electric eel acetylcholinesterase (AChE) and horse serum butyrylcholinesterase (BuChE). The IC50 of itopride with AChE (2.04+/-0.27 mu M) was, however, 100-fold less than that with BuChE, whereas in the case of neostigmine with AChE (11.3+/-3.4 nM), it was 10-fold less. The recovery of AChE activity inhibited by 10(-7) M neostigmine was partial, but that inhibited by upto 3 x 10(-5) M itopride was complete when the reaction mixture was subjected to ultrafiltration. Double reciprocal plots of the experimental data showed that both K-m and V-max were affected by itopride, suggesting that the inhibition is a ''mixed'' type, although primarily being an uncompetitive one. The inhibitory effect of itopride on cholinesterase (ChE) activity in guinea pig gastrointestine was much weaker than that on pure AChE. However, in the presence of a low dose of diisopropyl fluorophosphate, just enough to inhibit BuChE but not AChE, the IC(50)s of itopride against ChE activities were found to be about 0.5 mu M. In conclusion, itopride exerts reversible and a ''mixed'' type of inhibition preferably against AChE. The IC50 of itopride for electric eel and guinea pig gastrointestinal AChE inhibition was 200 times and 50 times as large as that of neostigmine, respectively.